ARTICLE | Product Development
Clinical trial and regulatory efficiency get help from ctDNA, RWE at ASCO19
ASCO19 abstracts showcase the power of ctDNA and real-world data to add speed, relevance to trials.
June 1, 2019 1:12 AM UTC
This year’s crop of ASCO abstracts show companies are going full bore on pre- and post-market technologies that can speed up development and regulatory timelines.
In BioCentury’s analysis of 4,627 abstracts, over 500 feature circulating tumor DNA or real-world evidence, and they showcase how companies, institutions and regulatory agencies are applying the technologies...